Univ Tx Sw Medctr Company Profile
What is the competitive landscape for UNIV TX SW MEDCTR
UNIV TX SW MEDCTR has two approved drugs.
Drugs and US Patents for Univ Tx Sw Medctr
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Univ Tx Sw Medctr | FLUDEOXYGLUCOSE F18 | fludeoxyglucose f-18 | INJECTABLE;INTRAVENOUS | 210265-001 | Feb 6, 2020 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Univ Tx Sw Medctr | AMMONIA N 13 | ammonia n-13 | INJECTABLE;INTRAVENOUS | 209507-001 | Nov 1, 2019 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

